- Home
- MRK vs GOOGM Comparison
MRK vs GOOGM Comparison
Compare MRK & GOOGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
GOOGM
Alphabet Inc. Depositary Shares representing a 1/20th Interest in a Share of Series A Mandatory Convertible Preferred Stock
Current Price
Company Overview
Basic Information| Metric | MRK | GOOGM |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | 624.3B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MRK | GOOGM |
|---|---|---|
| Price | $150.65 | $49.38 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | ★ 7.8M | 734.7K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | 8.01 | ★ 34.45 |
| EPS | N/A | ★ 14.24 |
| Revenue | $65,011,000,000.00 | ★ $402,836,000,000.00 |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $3.44 |
| Revenue Growth | 1.31 | ★ 15.09 |
| 52 Week Low | $77.58 | $46.24 |
| 52 Week High | $154.49 | $53.13 |
Technical Indicators
Market Signals| Indicator | MRK | GOOGM |
|---|---|---|
| Relative Strength Index (RSI) | 73.39 | 49.29 |
| Support Level | $113.32 | $48.45 |
| Resistance Level | N/A | $52.10 |
| Average True Range (ATR) | 3.69 | 0.79 |
| MACD | 2.03 | -0.09 |
| Stochastic Oscillator | 85.78 | 21.37 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).